A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19

Lignende værker

• Use of DPP-4 inhibitors in patients with COVID-19
  af: Kow, Chia Siang, et al.
  Udgivet: (2020)
• Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis
  af: Kow, Chia Siang, et al.
  Udgivet: (2021)
• Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
  af: Kow, Chia Siang, et al.
  Udgivet: (2021)
• Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?
  af: Kow, Chia Siang, et al.
  Udgivet: (2020)
• Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury
  af: Kow, Chia Siang, et al.
  Udgivet: (2020)